These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

628 related items for PubMed ID: 32328061

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Optimized clonotypic analysis of T-cell receptor repertoire in immune reconstitution.
    Packer AN, Muraro PA.
    Exp Hematol; 2007 Mar; 35(3):516-21. PubMed ID: 17309832
    [Abstract] [Full Text] [Related]

  • 24. Systematic literature review and network meta-analysis in highly active relapsing-remitting multiple sclerosis and rapidly evolving severe multiple sclerosis.
    Huisman E, Papadimitropoulou K, Jarrett J, Bending M, Firth Z, Allen F, Adlard N.
    BMJ Open; 2017 Mar 10; 7(3):e013430. PubMed ID: 28283486
    [Abstract] [Full Text] [Related]

  • 25. Rituximab for relapsing-remitting multiple sclerosis.
    He D, Guo R, Zhang F, Zhang C, Dong S, Zhou H.
    Cochrane Database Syst Rev; 2013 Dec 06; (12):CD009130. PubMed ID: 24310855
    [Abstract] [Full Text] [Related]

  • 26. CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire.
    Suessmuth Y, Mukherjee R, Watkins B, Koura DT, Finstermeier K, Desmarais C, Stempora L, Horan JT, Langston A, Qayed M, Khoury HJ, Grizzle A, Cheeseman JA, Conger JA, Robertson J, Garrett A, Kirk AD, Waller EK, Blazar BR, Mehta AK, Robins HS, Kean LS.
    Blood; 2015 Jun 18; 125(25):3835-50. PubMed ID: 25852054
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Flow cytometric analysis of TCR Vβ repertoire in patients with 22q11.2 deletion syndrome.
    McLean-Tooke A, Barge D, Spickett GP, Gennery AR.
    Scand J Immunol; 2011 Jun 18; 73(6):577-85. PubMed ID: 21323691
    [Abstract] [Full Text] [Related]

  • 31. Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study.
    Curro' D, Vuolo L, Gualandi F, Bacigalupo A, Roccatagliata L, Capello E, Uccelli A, Saccardi R, Sormani MP, Mancardi G.
    Mult Scler; 2015 Oct 18; 21(11):1423-30. PubMed ID: 25583838
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosis.
    Mariottini A, Nozzoli C, Carli I, Landi F, Gigli V, Repice AM, Ipponi A, Cecchi M, Boncompagni R, Saccardi R, Massacesi L.
    Neurol Sci; 2024 Jul 18; 45(7):3379-3387. PubMed ID: 38277051
    [Abstract] [Full Text] [Related]

  • 34. Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An Update.
    Lutter L, Spierings J, van Rhijn-Brouwer FCC, van Laar JM, van Wijk F.
    Front Immunol; 2018 Jul 18; 9():767. PubMed ID: 29731752
    [Abstract] [Full Text] [Related]

  • 35. CD4+ virtual memory: Antigen-inexperienced T cells reside in the naïve, regulatory, and memory T cell compartments at similar frequencies, implications for autoimmunity.
    Marusina AI, Ono Y, Merleev AA, Shimoda M, Ogawa H, Wang EA, Kondo K, Olney L, Luxardi G, Miyamura Y, Yilma TD, Villalobos IB, Bergstrom JW, Kronenberg DG, Soulika AM, Adamopoulos IE, Maverakis E.
    J Autoimmun; 2017 Feb 18; 77():76-88. PubMed ID: 27894837
    [Abstract] [Full Text] [Related]

  • 36. NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
    Ruder J, Rex J, Obahor S, Docampo MJ, Müller AMS, Schanz U, Jelcic I, Martin R.
    Front Immunol; 2021 Feb 18; 12():794077. PubMed ID: 34975899
    [Abstract] [Full Text] [Related]

  • 37. Natalizumab for relapsing remitting multiple sclerosis.
    Pucci E, Giuliani G, Solari A, Simi S, Minozzi S, Di Pietrantonj C, Galea I.
    Cochrane Database Syst Rev; 2011 Oct 05; (10):CD007621. PubMed ID: 21975773
    [Abstract] [Full Text] [Related]

  • 38. Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing-remitting multiple sclerosis subjects.
    Sweeney ME, Slusser JG, Lynch SG, Benedict SH, Garcia SL, Rues L, LeVine SM.
    Int Immunopharmacol; 2011 Nov 05; 11(11):1796-801. PubMed ID: 21807124
    [Abstract] [Full Text] [Related]

  • 39. Donor CD4 T Cell Diversity Determines Virus Reactivation in Patients After HLA-Matched Allogeneic Stem Cell Transplantation.
    Ritter J, Seitz V, Balzer H, Gary R, Lenze D, Moi S, Pasemann S, Seegebarth A, Wurdack M, Hennig S, Gerbitz A, Hummel M.
    Am J Transplant; 2015 Aug 05; 15(8):2170-9. PubMed ID: 25873100
    [Abstract] [Full Text] [Related]

  • 40. Comprehensive assessment of T-cell repertoire following autologous hematopoietic stem cell transplantation for treatment of type 1 diabetes using high-throughput sequencing.
    Zhang J, Hu M, Wang B, Gao J, Wang L, Li L, Chen S, Cui B, Gu W, Wang W, Ning G.
    Pediatr Diabetes; 2018 Nov 05; 19(7):1229-1237. PubMed ID: 30022578
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.